G. Galvan

Luteinizing hormone‐releasing hormone antagonist Cetrorelix (SB‐75) and bombesin antagonist RC‐3940‐II inhibit the growth of androgen‐independent PC‐3 prostate cancer in nude mice

A. Schally, K. Groot, K. Szepesházi, 1997, The Prostate.

Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment

L. Degraffenried, C. Jolly, M. Liss, 2017, Nutrition and cancer.

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

A. Schally, K. Groot, K. Szepesházi, 1997, European journal of cancer.

Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients.

S. Freedland, D. Theodorescu, D. Tyler, 2022, Urologic oncology.